JP2012512149A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512149A5
JP2012512149A5 JP2011540141A JP2011540141A JP2012512149A5 JP 2012512149 A5 JP2012512149 A5 JP 2012512149A5 JP 2011540141 A JP2011540141 A JP 2011540141A JP 2011540141 A JP2011540141 A JP 2011540141A JP 2012512149 A5 JP2012512149 A5 JP 2012512149A5
Authority
JP
Japan
Prior art keywords
formula
linker
conjugate
iii
platinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011540141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512149A (ja
JP5873719B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/067136 external-priority patent/WO2010069941A1/en
Publication of JP2012512149A publication Critical patent/JP2012512149A/ja
Publication of JP2012512149A5 publication Critical patent/JP2012512149A5/ja
Application granted granted Critical
Publication of JP5873719B2 publication Critical patent/JP5873719B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011540141A 2008-12-16 2009-12-15 白金含有化合物被覆ナノ粒子を含有するコンジュゲート Expired - Fee Related JP5873719B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08171870.2 2008-12-16
EP08171870 2008-12-16
PCT/EP2009/067136 WO2010069941A1 (en) 2008-12-16 2009-12-15 Conjugates comprising nanoparticles coated with platinum containing compounds

Publications (3)

Publication Number Publication Date
JP2012512149A JP2012512149A (ja) 2012-05-31
JP2012512149A5 true JP2012512149A5 (enExample) 2012-11-29
JP5873719B2 JP5873719B2 (ja) 2016-03-01

Family

ID=40568646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011540141A Expired - Fee Related JP5873719B2 (ja) 2008-12-16 2009-12-15 白金含有化合物被覆ナノ粒子を含有するコンジュゲート

Country Status (13)

Country Link
US (1) US9023370B2 (enExample)
EP (1) EP2379114B1 (enExample)
JP (1) JP5873719B2 (enExample)
CA (1) CA2745972C (enExample)
CY (1) CY1115601T1 (enExample)
DK (1) DK2379114T3 (enExample)
ES (1) ES2505890T3 (enExample)
HR (1) HRP20140804T1 (enExample)
IL (1) IL213408A (enExample)
PL (1) PL2379114T3 (enExample)
PT (1) PT2379114E (enExample)
SI (1) SI2379114T1 (enExample)
WO (1) WO2010069941A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909435D0 (en) * 2009-06-02 2009-07-15 Univ Strathclyde Nanoparticle for biomolecule delivery
ES2392528B1 (es) * 2010-12-28 2013-10-21 Endor Nanotechnologies, S.L. Sistema de liberación de agente terapéutico, composiciones farmacéuticas que lo contienen, su preparación y su uso médico.
ITRM20130138A1 (it) 2013-03-07 2014-09-08 Consiglio Nazionale Ricerche Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
JP6316011B2 (ja) * 2014-02-04 2018-04-25 国立大学法人滋賀医科大学 抗癌剤が担持されたナノ粒子
EP3409772B1 (en) * 2016-01-29 2023-06-28 National University Corporation Hokkaido University Intracellular substance transport system and use thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
EP3908324B1 (en) 2019-01-08 2022-05-11 Nanonica S.A. Conjugates comprising nanoparticles coated with platinum derivatives through sulfonyl or phosphonyl-containing linkers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851932B (enExample) 1984-08-14 1985-12-13 Engelhard Corp
JP2866554B2 (ja) 1992-08-25 1999-03-08 松下電器産業株式会社 情報記録媒体とその製造方法及び情報記録媒体の使用方法
CA2487720A1 (en) 2002-06-03 2003-12-11 Alnis Biosciences, Inc. Therapeutic agent-containing polymeric nanoarticles
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
US8785505B2 (en) * 2005-10-28 2014-07-22 The Regents Of The University Of California Toxicology and cellular effect of manufactured nanomaterials

Similar Documents

Publication Publication Date Title
JP2012512149A5 (enExample)
JP2011511073A5 (enExample)
JP2012528240A5 (enExample)
HRP20140804T1 (hr) Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu
JP2010539082A5 (enExample)
Wang et al. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging
CN102037058A (zh) 多西紫杉醇高分子衍生物、及其制造方法及其用途
JP2011523643A5 (enExample)
JP2010528122A5 (enExample)
RU2013117441A (ru) Пролекарства, содержащие конъюгат эксендин-линкер
JP2010526917A5 (enExample)
WO2018171164A1 (zh) 一种喜树碱类前药及其制备和应用
JP7764041B2 (ja) 脳腫瘍における改善された血液脳関門浸透性及び滞留性を備えた、スケーラブルなチロインテグリンアンタゴニストの組成物
JP2018513875A5 (enExample)
JP2025534729A (ja) α型葉酸受容体を標的とするペメトレキセド近赤外蛍光分子の蛍光トレーサーとしての用途
CN1241576C (zh) 化学螯合剂用于制备逆转临床使用的神经肌肉传导阻滞剂药物诱发的神经肌肉传导阻滞的药物的用途
JP2007500734A5 (enExample)
CN107660210A (zh) 基于硼替佐米的递送系统
CN102727905A (zh) 一种金纳米-紫杉醇结合物及其制备方法和应用
WO2006098496A1 (ja) ジアミノシクロヘキサン白金(ii)とブロック共重合体との配位化合物及びそれを含有する抗がん剤
CN108976318B (zh) 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用
TWI233929B (en) Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
JP2007515399A5 (enExample)
JPWO2021200131A5 (enExample)
Bhattacharyya et al. Synthesis of 1, 2, 3-triazole linked 5 fluorouracil-carbon dots-folate conjugates for target specific anticancer activity and cell imaging applications